Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $562000.0.

  • Arcutis Biotherapeutics' Amortizatization of Intangibles fell 6678.49% to $562000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 218.12%. This contributed to the annual value of $6.9 million for FY2024, which is 125.91% down from last year.
  • Arcutis Biotherapeutics' Amortizatization of Intangibles amounted to $562000.0 in Q3 2025, which was down 6678.49% from $563000.0 recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Amortizatization of Intangibles high stood at $188.0 million for Q3 2023, and its period low was -$1.2 million during Q3 2021.
  • In the last 5 years, Arcutis Biotherapeutics' Amortizatization of Intangibles had a median value of $562000.0 in 2025 and averaged $10.4 million.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Amortizatization of Intangibles crashed by 387931.03% in 2021, and later surged by 15030000.0% in 2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Amortizatization of Intangibles (Quarter) stood at -$885000.0 in 2021, then skyrocketed by 327.8% to $2.0 million in 2022, then dropped by 26.98% to $1.5 million in 2023, then dropped by 25.54% to $1.1 million in 2024, then tumbled by 48.72% to $562000.0 in 2025.
  • Its last three reported values are $562000.0 in Q3 2025, $563000.0 for Q2 2025, and $3.0 million during Q1 2025.